| http://www.w3.org/ns/prov#value | - Dodds Chris M CM Experimental Medicine, GlaxoSmithKline Pharmaceuticals, Clinical Unit Cambridge, Addenbrooke's Centre for Clinical Investigation, Box 128, Addenbrooke's Hospital, Hills Road, Cambridge CB2 2QQ, UK. - - 2012 The dopamine D(3) receptor is thought to be a potential target for treating compulsive disorders such as drug addiction and obesity.
|
